Nrf2 Activation by Curcumin Improves Exercise Performance of Mice with Chronic Heart Failure
Lie Gao,Tara L. Rudebush,Ahmed M. Wafi,Irving H. Zucker,Harold D. Schultz
DOI: https://doi.org/10.1096/fasebj.31.1_supplement.1020.15
2017-01-01
Abstract:One of the hallmarks in chronic heart failure (CHF) is exercise intolerance, which profoundly impacts patients' quality of life and worsens prognosis. There are no effective pharmacological interventions to preserve exercise capacity in CHF. It is well known that the CHF syndrome is associated with global oxidative stress. Reactive oxygen species (ROS) accumulate in myocytes to cause oxidative modification of nucleic acids, lipids, and proteins, leading to structural and functional deterioration in skeletal muscle in the CHF state. Accordingly, antioxidant interventions are a potential therapeutic strategy to prevent or reverse exercise intolerance in this syndrome. In the present study, we hypothesized that, in skeletal muscle, activation of Nrf2, a principle transcription factor responsible for the expression of a broad array of antioxidant enzymes, can improve exercise performance in CHF by activating endogenous antioxidant mechanisms to restore redox homeostasis. The experiment was carried out in coronary artery ligation-induced CHF mice, which were given the Nrf2 activator curcumin (Cur, 50 mg/kg/day) via osmotic minipumps beginning 12 wks after ligation. After 8 wks of treatment, exercise performance, muscle contractility, antioxidant enzymes, and ROS levels were evaluated. We found that: (1) CHF mice displayed a significantly slower maximal treadmill speed and shorter running distance than sham mice, which was improved by Cur (Maximal Speed: Sham 33.4 ± 0.7, CHF 17.1 ± 1.9, CHF + Cur 24.9 ± 1.2 m/min; Total Distance until exhaustion: Sham 573.3 ± 28.2, CHF 215.8 ± 13.9, CHF + Cur 352.4 ± 11.8 m, P < 0.05, n = 7 for each group); (2) Total limb grip force generated in response to tail pinch was lower in CHF and was improved by Cur (Sham 14.9 ± 1.1, CHF 7.1 ± 0.9, CHF + Cur 12.6 ± 1.3 g/g body weight, P < 0.05, n = 7 for each group); (3) In situ force fatigue test demonstrated that, in sham mice, soleus (Sol) displayed a greater resistance to fatigue than extensor digitorum longus (EDL) consistent with constituent fiber types. The Sol (oxidative fiber type) of CHF mice exhibited a greater and more rapid fatigue than Sol of sham mice, which was improved by Cur. However, there was no apparent difference in maximal fatigue development in EDL (glycolytic fiber type) among these groups. See the attached Figure; (4) In both Sol and EDL, Nrf2, HO-1, SOD2, Myogenin, and MyoD expression were lower and ROS and ubiquitinated proteins were higher in CHF compared to sham. These changes were attenuated by Cur. The above data indicate that CHF mice exhibit an impaired exercise performance and decline in muscle strength accompanied by down regulated Nrf2 and antioxidant enzymes and elevated ROS and activated ubiquitin-proteasome system (UPS). These alterations were attenuated by Cur. These data suggest that the suppressed Nrf2 signaling in skeletal muscle contributes to exercise intolerance in CHF, and Nrf2 activation is a novel therapeutic strategy to ameliorate exercise capacity in CHF. Support or Funding Information University of Nebraska Medical Center Intramural Grant; P01 HL62222 Fiber type distribution (A), Nrf2 protein expression (B), and in situ muscle contractile test (C) for fatigue profile (i) and tetanic properties (ii) in oxidative Sol muscle and glycolytic EDL muscle of sham and CHF mice. Fiber type distribution (A), Nrf2 protein expression (B), and in situ muscle contractile test (C) for fatigue profile (i) and tetanic properties (ii) in oxidative Sol muscle and glycolytic EDL muscle of sham and CHF mice.